Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Simsek, Suat ^b,c   Van Den Oever, Inge A M ^a   Raterman, Hennie G ^b   Nurmohamed, Mike T ^a,b  

^a JAN VAN BREEMEN INSTITUTE   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Location Alkmaar   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; ANGIOTENSIN II; CERAMIDE; COLLAGEN; CYTOCHROME C; DIACYLGLYCEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR; POLYOL; PROSTACYCLIN; PROTEIN KINASE C; RESISTIN; SORBITOL; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADIPOSE TISSUE; AGING; APOPTOSIS; ARTERY ENDOTHELIUM; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; DIABETIC PATIENT; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; MICROVASCULATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; DIABETES MELLITUS; IMMUNOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

APOPTOSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; SIGNAL TRANSDUCTION;

EID: 77954545549     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/792393     Document Type: Review

References (96)

1. King H., Aubert R. E., Herman W. H., Global burden of diabetes, 19952025: prevalence, numerical estimates, and projections Diabetes Care 1998 21 9 1414 1431
2. International Diabetes Federation, The Diabetes Atlas 2006 3rd
3. De Caterina R., Endothelial dysfunctions: common denominators in vascular disease Current Opinion in Lipidology 2000 11 1 9 23
4. Stehouwer C. D. A., Lambert J., Donker A. J. M., Van Hinsbergh V. W. M., Endothelial dysfunction and pathogenesis of diabetic angiopathy Cardiovascular Research 1997 34 1 55 68
5. Schalkwijk C. G., Stehouwer C. D. A., Vascular complications in diabetes mellitus: the role of endothelial dysfunction Clinical Science 2005 109 2 143 159
6. Cubbon R. M., Rajwani A., Wheatcroft S. B., The impact of insulin resistance on endothelial function, progenitor cells and repair Diabetes and Vascular Disease Research 2007 4 2 103 111
7. Hadi H. A. R., Al Suwaidi J. A., Endothelial dysfunction in diabetes mellitus Vascular Health and Risk Management 2007 3 6 853 876
8. Libby P., Inflammation in atherosclerosis Nature 2002 420 6917 868 874
9. Goldschmidt-Clermont P. J., Creager M. A., Lorsordo D. W., Lam G. K. W., Wassef M., Dzau V. J., Atherosclerosis 2005: recent discoveries and novel hypotheses Circulation 2005 112 21 3348 3353
10. Quyyumi A. A., Endothelial function in health and disease: new insights into the genesis of cardiovascular disease American Journal of Medicine 1998 105 1 32S 39S
11. Cowan D. B., Langille B. L., Cellular and molecular biology of vascular remodeling Current Opinion in Lipidology 1996 7 2 94 100
12. Tracy R. P., Lemaitre R. N., Psaty B. M., Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 6 1121 1127
13. Biegelsen E. S., Loscalzo J., Endothelial function and atherosclerosis Coronary Artery Disease 1999 10 4 241 256
14. Tan K. C. B., Chow W.-S., Ai V. H. G., Lam K. S. L., Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria Diabetes/Metabolism Research and Reviews 2002 18 1 71 76
15. Verma S., Anderson T. J., Fundamentals of endothelial function for the clinical cardiologist Circulation 2002 105 5 546 549 (Pubitemid 34123425)
16. Kawashima S., The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis Endothelium 2004 11 2 99 107 (Pubitemid 39207183)
17. Khan B. V., Harrison D. G., Olbrych M. T., Alexander R. W., Medford R. M., Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells Proceedings of the National Academy of Sciences of the United States of America 1996 93 17 9114 9119
18. Janssen-Heininger Y. M. W., Poynter M. E., Baeuerle P. A., Recent advances towards understanding redox mechanisms in the activation of nuclear factor B Free Radical Biology and Medicine 2000 28 9 1317 1327
19. Jansson P.-A., Endothelial dysfunction in insulin resistance and type 2 diabetes Journal of Internal Medicine 2007 262 2 173 183
20. Mombouli J.-V., ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide Drugs 1997 54 supplement 5 12 22
21. Luscher T. F., Tanner F. C., Tschudi M. R., Noll G., Endothelial dysfunction in coronary artery disease Annual Review of Medicine 1993 44 395 418
22. Harrison D. G., Cellular and molecular mechanisms of endothelial cell dysfunction Journal of Clinical Investigation 1997 100 9 2153 2157
23. Tan C., Dlugosz P. J., Peng J., Auto-activation of the apoptosis protein bax increases mitochondrial membrane permeability and is inhibited by Bcl-2 Journal of Biological Chemistry 2006 281 21 14764 14775
24. Yang Z., Mo X., Gong Q., Critical effect of VEGF in the process of endothelial cell apoptosis induced by high glucose Apoptosis 2008 13 11 1331 1343
25. Zamzami N., Brenner C., Marzo I., Susin S. A., Kroemer G., Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins Oncogene 1998 16 17 2265 2282
26. Yasuda O., Fukuo K., Sun X., Apop-1, a novel protein inducing cyclophilin D-dependent but Bax/Bak-related channel-independent apoptosis Journal of Biological Chemistry 2006 281 33 23899 23907
27. Nakagami H., Morishita R., Yamamoto K., Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells Diabetes 2001 50 6 1472 1481
28. Kluck R. M., Bossy-Wetzel E., Green D. R., Newmeyer D. D., The release of cytochrome c from mitochondria: a primary site for Bcl- 2 regulation of apoptosis Science 1997 275 5303 1132 1136
29. Davidson S. M., Duchen M. R., Endothelial mitochondria: contributing to vascular function and disease Circulation Research 2007 100 1128 1141
30. Baumgartner-Parzer S. M., Wagner L., Pettermann M., Grillari J., Gessl A., Waldhausl W., High-glucose-triggered apoptosis in cultured endothelial cells Diabetes 1995 44 11 1323 1327
31. Favaro E., Miceli I., Bussolati B., Hyperglycemia induces apoptosis of human pancreatic islet endothelial cells: effects of pravastatin on the Akt survival pathway American Journal of Pathology 2008 173 2 442 450
32. Ho F. M., Liu S. H., Liau C. S., Huang P. J., Lin-Shiau S. Y., High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-JUN NH2-terminal kinase and caspase-3 Circulation 2000 101 22 2618 2624
33. Ido Y., Carling D., Ruderman N., Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation Diabetes 2002 51 1 159 167
34. Lorenzi M., Cagliero E., Pathobiology of endothelial and other vascular cells in diabetes mellitus. Call for data Diabetes 1991 40 6 653 659
35. Cines D. B., Pollak E. S., Buck C. A., Endothelial cells in physiology and in the pathophysiology of vascular disorders Blood 1998 91 10 3527 3561
36. Goligorsky M. S., Chen J., Brodsky S., Endothelial cell dysfunction leading to diabetic nephropathy focus on nitric oxide Hypertension 2001 37 2 744 748
37. Flyvbjerg A., Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease Diabetologia 2000 43 10 1205 1223
38. Shamoon H., Duffy H., Fleischer N., The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus New England Journal of Medicine 1993 329 14 977 986
39. Holman R. R., Cull C. A., Fox C., Turner R. C., United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years British Medical Journal 1995 310 6972 83 88
40. Calles-Escandon J., Cipolla M., Diabetes and endothelial dysfunction: a clinical perspective Endocrine Reviews 2001 22 1 36 52
41. Kahn B. B., Flier J. S., Obesity and insulin resistance Journal of Clinical Investigation 2000 106 4 473 481
42. Haffner S. M., Pre-diabetes, insulin resistance, inflammation and CVD risk Diabetes Research and Clinical Practice 2003 61 supplement 1 S9 S18
43. Taskinen M.-R., Type 2 diabetes as a lipid disorder Current Molecular Medicine 2005 5 3 297 308
44. Artwohl M., Graier W. F., Roden M., Diabetic LDL triggers apoptosis in vascular endothelial cells Diabetes 2003 52 5 1240 1247
45. Madonna R., Massaro M., De Caterina R., Insulin potentiates cytokine-induced VCAM-1 expression in human endothelial cells Biochimica et Biophysica Acta 2008 1782 9 511 516
46. Kim J.-A., Montagnani M., Kwang K. K., Quon M. J., Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms Circulation 2006 113 15 1888 1904
47. Jiang Z. Y., Zhou Q.-L., Chatterjee A., Endothelin-1 modulates insulin signaling through phosphatidylinositol 3- kinase pathway in vascular smooth muscle cells Diabetes 1999 48 5 1120 1130
48. Strawbridge A. B., Elmendorf J. S., Endothelin-1 impairs glucose transporter trafficking via a membrane-based mechanism Journal of Cellular Biochemistry 2006 97 4 849 856
49. Serne E. H., Gans R. O. B., ter Maaten J. C., ter Wee P. M., Donker A. J. M., Stehouwer C. D. A., Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions Cardiovascular Research 2001 49 1 161 168
50. Goldstein B. J., Scalia R. G., Ma X. L., Protective vascular and myocardial effects of adiponectin Nature Clinical Practice Cardiovascular Medicine 2009 6 1 27 35
51. Ouchi N., Kihara S., Arita Y., Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 2001 103 8 1057 1063
52. Desideri G., Ferri C., Bellini C., De Mattia G., Santucci A., Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion: in vitro and in vivo studies Diabetes 1997 46 1 81 86
53. Pastore L., Tessitore A., Martinotti S., Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo Circulation 1999 100 15 1646 1652
54. Rajagopalan S., Kurz S., Munzel T., Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone Journal of Clinical Investigation 1996 97 8 1916 1923
55. Yusuf S., Gerstein H., Hoogwerf B., Ramipril and the development of diabetes Journal of the American Medical Association 2001 286 15 1882 1885
56. Federici M., Pandolfi A., De Filippis E. A., G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells Circulation 2004 109 3 399 405
57. Sandqvist M., Nyberg G., Hammarstedt A., Low adipocyte IRS-1 protein expression is associated with an increased arterial stiffness in non-diabetic males Atherosclerosis 2005 180 1 119 125
58. van Eijk I. C., Peters M. J. L., Serne E. H., Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor blockade Annals of the Rheumatic Diseases 2009 68 3 362 366
59. Folsom A. R., Rosamond W. D., Shahar E., Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) study investigators Circulation 1999 100 7 736 742
60. Grau A. J., Buggle F., Becher H., Werle E., Hacke W., The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases Thrombosis Research 1996 82 3 245 255
61. Shurtz-Swirski R., Sela S., Herskovits A. T., Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients Diabetes Care 2001 24 1 104 110
62. Aoki M., Nata T., Morishita R., Endothelial apoptosis induced by oxidative stress through activation of NF- B: antiapoptotic effect of antioxidant agents on endothelial cells Hypertension 2001 38 1 48 55
63. Venugopal S. K., Devaraj S., Yuhanna I., Shaul P., Jialal I., Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells Circulation 2002 106 12 1439 1441
64. Pasceri V., Willerson J. T., Yeh E. T. H., Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 2000 102 18 2165 2168
65. Behl Y., Krothapalli P., Desta T., Roy S., Graves D. T., FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats Diabetes 2009 58 4 917 925
66. Behl Y., Krothapalli P., Desta T., DiPiazza A., Roy S., Graves D. T., Diabetes-enhanced tumor necrosis factor- production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy American Journal of Pathology 2008 172 5 1411 1418
67. Zauli G., Pandolfi A., Gonelli A., Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells Circulation Research 2003 92 7 732 740
68. Moran C. S., McCann M., Karan M., Norman P., Ketheesan N., Golledge J., Association of osteoprotegerin with human abdominal aortic aneurysm progression Circulation 2005 111 23 3119 3125
69. Ueland T., Jemtland R., Godang K., Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction Journal of the American College of Cardiology 2004 44 10 1970 1976
70. Vaccarezza M., Delbello G., Zauli G., A role of the TRAIL-TRAIL receptor system in the pathogenesis of diabetes Acta Bio-Medica 2007 78, supplement 1 262 267
71. Venugopal S. K., Devaraj S., Jialal I., Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role Current Opinion in Nephrology and Hypertension 2005 14 1 33 37
72. Alexiewicz J. M., Kumar D., Smogorzewski M., Klin M., Massry S. G., Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function Annals of Internal Medicine 1995 123 12 919 924
73. Abu El-Asrar A. M., Soliman R. T., Al-Amro S. A., Al-Shammary F. J., Serum factor from diabetic patients with or without retinopathy stimulates superoxide anion production by normal polymorphonuclear leukocytes Documenta Ophthalmologica 1995 91 1 1 8
74. Evans M., Khan N., Rees A., Diabetic dyslipidaemia and coronary heart disease: new perspectives Current Opinion in Lipidology 1999 10 5 387 391
75. Dagher Z., Park Y. S., Asnaghi V., Hoehn T., Gerhardinger C., Lorenzi M., Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy Diabetes 2004 53 9 2404 2411
76. Gabbay K. H., Hyperglycemia, polyol metabolism, and complications of diabetes mellitus Annual Review of Medicine 1975 26 521 536
77. Du X.-L., Edelstein D., Rossetti L., Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation Proceedings of the National Academy of Sciences of the United States of America 2000 97 22 12222 12226
78. Way K. J., Katai N., King G. L., Protein kinase C and the development of diabetic vascular complications Diabetic Medicine 2001 18 12 945 959
79. Idris I., Gray S., Donnelly R., Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes Diabetologia 2001 44 6 659 673
80. Williams B., Gallacher B., Patel H., Orme C., Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro Diabetes 1997 46 9 1497 1503
81. Chen S., Apostolova M. D., Cherian M. G., Chakrabarti S., Interaction of endothelin-1 with vasoactive factors in mediating glucose-induced increased permeability in endothelial cells Laboratory Investigation 2000 80 8 1311 1321
82. Geraldes P., Hiraoka-Yamamoto J., Matsumoto M., Activation of PKC-and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy Nature Medicine 2009 15 11 1298 1306
83. Vlassara H., Striker L. J., Teichberg S., Fuh H., Li Y. M., Steffes M., Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats Proceedings of the National Academy of Sciences of the United States of America 1994 91 24 11704 11708
84. Stern D. M., Yan S. D., Yan S. F., Schmidt A. M., Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes Ageing Research Reviews 2002 1 1 1 15
85. Peppa M., Vlassara H., Advanced glycation end products and diabetic complications: a general overview Hormones 2005 4 1 28 37
86. Cohen M. P., Ziyadeh F. N., Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy Journal of the American Society of Nephrology 1996 7 2 183 190
87. Jakus V., Rietbrock N., Advanced glycation end-products and the progress of diabetic vascular complications Physiological Research 2004 53 2 131 142
88. Srinivasan S., Hatley M. E., Bolick D. T., Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells Diabetologia 2004 47 10 1727 1734
89. Guzik T. J., Mussa S., Gastaldi D., Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase Circulation 2002 105 14 1656 1662
90. Du X. L., Sui G. Z., Stockklauser-Farber K., Induction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species Diabetologia 1998 41 3 249 256
91. Madamanchi N. R., Vendrov A., Runge M. S., Oxidative stress and vascular disease Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 1 29 38
92. El-Osta A., Brasacchio D., Yao D., Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia Journal of Experimental Medicine 2008 205 10 2409 2417
93. Yokoi T., Fukuo K., Yasuda O., Apoptosis signal-regulating kinase 1 mediates cellular senescence induced by high glucose in endothelial cells Diabetes 2006 55 6 1660 1665
94. Lorenzi M., Cagliero E., Toledo S., Glucose toxicity for human endothelial cells in culture: delayed replication, disturbed cell cycle, and accelerated death Diabetes 1985 34 7 621 627
95. Ho F. M., Lin W. W., Chen B. C., High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF- B and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway Cellular Signalling 2006 18 3 391 399
96. Sheu M. L., Ho F. M., Yang R. S., High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 3 539 545